advertisement
Abstract #13097 Published in IGR 7-3
Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells
Saito S; Ohashi M; Naito A; Fukaya Y; Suzuki Y; Araie MJapanese Journal of Ophthalmology 2005; 49: 371-376
PURPOSE: To investigate whether NS-7, 4-(4-fluorophenyl)-2-methyl-6-(5-piperidinopentyloxy) pyrimidine hydrochloride, a novel Na+ /Ca2+ channel blocker, can protect the rat retina subjected to ischemia-reperfusion insult. METHODS: To evaluate the protective effect of NS-7 against retinal damage, the drug was administered before and after ischemia-reperfusion. Damage to the retina was assessed by measuring the thickness of the inner plexiform layer (IPL) and the outer nuclear layer (ONL) of each eye. In a subsequent experiment, electroretinographic (ERG) evaluation was also used. RESULTS: In histopathologic evaluation, ischemia-reperfusion injury caused a significant reduction of IPL thickness (measured as the IPL/ONL ratio). In the NS-7-treated group, retinal damage was partially prevented by a concentration of 0.25 mg/kg per day. In the ERG evaluation, ischemia-reperfusion injury caused a reduction of A- and B-wave amplitudes. NS-7 treatment significantly prevented the reduction of the B wave at a concentration of 0.1 or 0.3 mg/kg, while the reduction of the A wave was not significantly affected. CONCLUSIONS: NS-7 has neuroprotective effects against retinal damage resulting from subjection to ischemia. In addition, NS-7 can be used as an agent for treating acute ischemic retinopathy, including diseases associated with very high intraocular pressure, such as acute angle-closure glaucoma.
Dr. S. Saito, Department of Ophthalmology, Nippon Medical School, Tokyo, Japan. saito@nms.ac.jp
Classification:
11.8 Neuroprotection (Part of: 11 Medical treatment)
